Ireland - English - HPRA (Health Products Regulatory Authority)

fannin limited - epirubicin - solution for inj/inf - 2 mg/ml - anthracyclines and related substances

Ireland - English - HPRA (Health Products Regulatory Authority)

strides arcolab international limited - mitoxantrone - concentrate for soln for inf - 2 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - powder for solution for injection - 10 milligram(s) - anthracyclines and related substances; idarubicin

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - powder for solution for injection - 5 milligram(s) - anthracyclines and related substances; idarubicin

Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - doxorubicin hydrochloride - injection - 2.00 mg/ml - doxorubicin hydrochloride 2.00 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - doxorubicin hydrochloride - concentrate for solution for infusion - 2 mg/ml - antineoplastic agents and anthracyclines and related substances - it is used for: small-cell lung cancer (sclc); breast cancer; recurrent ovarian carcinoma; intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection (tur); systemic treatment of local advanced or metastasized bladder carcinoma; neoadjuvant and adjuvant therapy of osteosarcoma; advanced soft-tissue sarcoma in adults; ewing’s sarcoma; hodgkin’s lymphoma; highly malignant non-hodgkin’s lymphoma; induction and consolidation therapy in acute lymphatic leukaemia; acute myeloblastic leukaemia; advanced multiple myeloma; advanced or recurrent endometrial carcinoma; wilms’ tumour (in stage ii in highly malignant variants, all advanced stages [iii – iv]); advanced papillary/follicular thyroid cancer; anaplastic thyroid cancer; advanced neuroblastoma

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - doxorubicin hydrochloride - powder for concentrate for solution for infusion - 2 mg for one ml of reconstituted solution - antineoplastic agents and anthracyclines and related substances - it is indicated for: small-cell lung cancer (sclc); breast cancer; recurrent ovarian carcinoma; intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection (tur); systemic treatment of local advanced or metastasized bladder carcinoma; neoadjuvant and adjuvant therapy of osteosarcoma; advanced soft-tissue sarcoma in adults; ewing’s sarcoma; hodgkin’s lymphoma; highly malignant non-hodgkin’s lymphoma; induction and consolidation therapy in acute lymphatic leukaemia; acute myeloblastic leukaemia; advanced multiple myeloma; advanced or recurrent endometrial carcinoma; wilms’ tumour (in stage ii in highly malignant variants, all advanced stages [iii – iv]); advanced papillary/follicular thyroid cancer; anaplastic thyroid cancer; advanced neuroblastoma

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - doxorubicin hydrochloride - powder for concentrate for solution for infusion - 2 mg for 1 ml of reconstituted solution - antineoplastic agents and anthracyclines and related substances - it is indicated for: small-cell lung cancer (sclc); breast cancer; recurrent ovarian carcinoma; intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection (tur); systemic treatment of local advanced or metastasized bladder carcinoma; neoadjuvant and adjuvant therapy of osteosarcoma; advanced soft-tissue sarcoma in adults; ewing’s sarcoma; hodgkin’s lymphoma; highly malignant non-hodgkin’s lymphoma; induction and consolidation therapy in acute lymphatic leukaemia; acute myeloblastic leukaemia; advanced multiple myeloma; advanced or recurrent endometrial carcinoma; wilms’ tumour (in stage ii in highly malignant variants, all advanced stages [iii – iv]); advanced papillary/follicular thyroid cancer; anaplastic thyroid cancer; advanced neuroblastoma

Malta - English - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg - antineoplastic agents

Malta - English - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents